Orchard Therapeutics Announces Board Reshuffle Following Transaction

Orchard Therapeutics PLC (ORTX) has released an update to notify the public and investors about its officers.

Alicia Secor, Charles Rowland, Jim Geraghty, John Curnutte, Joanne Beck, Steven Altschuler, and Marc Dunoyer resigned from their positions on the Board of Directors and all board committees at the effective time of a recent transaction. Subsequently, on January 24, 2024, Takeyoshi Yamashita, Yasuo Fujii, and Abdul Mullick were appointed as directors of the Company.

For further insights into ORTX corporate activity, check out TipRanks’ Insiders Trading Activity page.